• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病患者循环 25 羟维生素 D 水平与甲状旁腺激素的关系:阈值得探索。

Relation between circulating levels of 25(OH) vitamin D and parathyroid hormone in chronic kidney disease: quest for a threshold.

机构信息

Institut National de la Santé et de la Recherche Médicale, Centre for Research in Epidemiology and Population Health, CESP, U1018, Diabetes, Obesity, and Chronic Kidney Disease Epidemiology Team, 94807 Villejuif, France.

出版信息

J Clin Endocrinol Metab. 2013 Jul;98(7):2922-8. doi: 10.1210/jc.2013-1294. Epub 2013 Apr 30.

DOI:10.1210/jc.2013-1294
PMID:23633202
Abstract

CONTEXT

Vitamin D deficiency is common in patients with chronic kidney disease (CKD). Current guidelines recommend treatment strategies in these patients similar to those for the general population, but the vitamin D nutritional status sufficient to prevent PTH levels from increasing in CKD is unknown. OBJECTIVE, MAIN OUTCOME MEASURE: Our aim was to study the relation between circulating PTH and 25(OH)D levels and to search for a 25(OH)D threshold associated with a significant PTH increase.

DESIGN, SETTING, AND PATIENTS: In the hospital-referred NephroTest cohort study, we measured 25(OH)D, PTH, and glomerular filtration rate (mGFR) by ⁵¹Cr-EDTA renal clearance in 929 adult patients with nondialysis CKD stages 1 to 5 and no vitamin D supplementation. Patients' mean age was 60.1 ± 14.7 years; 71% were men, and 9% were black. Their median mGFR was 37.8 mL/min/1.73 m².

RESULTS

We found a 25(OH)D threshold of 8 ng/mL with an upper limit of 20 ng/mL (95% confidence interval) by linear piecewise regression modeling of log-PTH for 25(OH)D adjusted for mGFR, age, race, and ionized calcium level. The smoothed curve confirmed that PTH concentration rose steeply when circulating 25(OH)D levels fell to less than 20 ng/mL.

CONCLUSIONS

Spontaneous 25(OH)D levels greater than 20 ng/mL seem sufficient to control serum PTH in CKD patients. This result reinforces guidelines to supplement vitamin D only if less than 30 ng/mL.

摘要

背景

维生素 D 缺乏在慢性肾脏病(CKD)患者中很常见。目前的指南建议这些患者的治疗策略与普通人群相似,但预防 CKD 患者甲状旁腺激素(PTH)水平升高所需的维生素 D 营养状态尚不清楚。目的、主要观察指标:我们旨在研究循环 PTH 与 25(OH)D 水平之间的关系,并寻找与 PTH 显著升高相关的 25(OH)D 阈值。设计、地点和患者:在医院转诊的 NephroTest 队列研究中,我们通过 ⁵¹Cr-EDTA 肾清除率测量了 929 例非透析 CKD 1 至 5 期且无维生素 D 补充的成年患者的 25(OH)D、PTH 和肾小球滤过率(mGFR)。患者的平均年龄为 60.1 ± 14.7 岁;71%为男性,9%为黑人。他们的中位 mGFR 为 37.8 mL/min/1.73 m²。结果:我们通过线性分段回归模型对 25(OH)D 进行了对数-PTH 建模,调整了 mGFR、年龄、种族和离子钙水平,发现 25(OH)D 的阈值为 8ng/mL,上限为 20ng/mL(95%置信区间)。平滑曲线证实,当循环 25(OH)D 水平降至 20ng/mL 以下时,PTH 浓度急剧上升。结论:自发 25(OH)D 水平大于 20ng/mL 似乎足以控制 CKD 患者的血清 PTH。这一结果强化了仅在低于 30ng/mL 时补充维生素 D 的指南。

相似文献

1
Relation between circulating levels of 25(OH) vitamin D and parathyroid hormone in chronic kidney disease: quest for a threshold.慢性肾脏病患者循环 25 羟维生素 D 水平与甲状旁腺激素的关系:阈值得探索。
J Clin Endocrinol Metab. 2013 Jul;98(7):2922-8. doi: 10.1210/jc.2013-1294. Epub 2013 Apr 30.
2
The impact of vitamin D status on the relative increase in fibroblast growth factor 23 and parathyroid hormone in chronic kidney disease.维生素 D 状态对慢性肾脏病中成纤维细胞生长因子 23 和甲状旁腺激素相对增加的影响。
Kidney Int. 2014 Aug;86(2):407-13. doi: 10.1038/ki.2013.537. Epub 2014 Jan 15.
3
Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis.血液透析的慢性肾脏病5期患者中25(羟)维生素D不足和缺乏的患病率。
Hemodial Int. 2007 Jul;11(3):315-21. doi: 10.1111/j.1542-4758.2007.00186.x.
4
Association of kidney function, vitamin D deficiency, and circulating markers of mineral and bone disorders in CKD.慢性肾脏病患者的肾功能、维生素 D 缺乏症、以及矿物质和骨代谢紊乱的循环标志物之间的关系。
Am J Kidney Dis. 2011 Oct;58(4):544-53. doi: 10.1053/j.ajkd.2011.04.029. Epub 2011 Jul 31.
5
Cholecalciferol v. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trial.胆钙化醇与麦角钙化醇用于慢性肾脏病患者补充25-羟维生素D(25(OH)D)的随机临床试验
Br J Nutr. 2016 Dec;116(12):2074-2081. doi: 10.1017/S000711451600427X. Epub 2017 Jan 9.
6
Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low.目前推荐的用于慢性肾脏病管理的25-羟基维生素D目标值可能过低。
J Nephrol. 2016 Feb;29(1):63-70. doi: 10.1007/s40620-015-0186-0. Epub 2015 Mar 4.
7
The effect of some medications given to CKD patients on vitamin D levels.一些用于 CKD 患者的药物对维生素 D 水平的影响。
Nefrologia. 2015;35(2):150-6. doi: 10.1016/j.nefro.2015.05.016. Epub 2015 Jun 23.
8
On-line haemodiafiltration improves response to calcifediol treatment.在线血液透析滤过可改善钙三醇治疗的反应。
Nefrologia. 2012 Jul 17;32(4):459-66. doi: 10.3265/Nefrologia.pre2012.Jan.11189.
9
Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.慢性肾脏病 1 至 5 期的分泌性 Klotho 和 FGF23:一项横断面研究提示的序列。
Nephrol Dial Transplant. 2013 Feb;28(2):352-9. doi: 10.1093/ndt/gfs460. Epub 2012 Nov 4.
10
[Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].3、4、5期慢性肾脏病(未透析)患者矿物质代谢的变化
Nefrologia. 2008;28 Suppl 3:67-78.

引用本文的文献

1
The association between 25-hydroxyvitamin D and parathyroid hormone in adolescents living with HIV in southern Africa: a cross-sectional study.南非青少年艾滋病毒感染者中25-羟基维生素D与甲状旁腺激素之间的关联:一项横断面研究。
Br J Nutr. 2025 Mar 13;133(7):1-7. doi: 10.1017/S0007114525000509.
2
Modeling calcium and magnesium balance: Regulation by calciotropic hormones and adaptations under varying dietary intake.钙和镁平衡建模:钙调节激素的调节作用及不同饮食摄入情况下的适应性变化
iScience. 2024 Sep 30;27(11):111077. doi: 10.1016/j.isci.2024.111077. eCollection 2024 Nov 15.
3
Highly-Sensitive In Vitro Bioassays for FSH, TSH, PTH, Kp, and OT in Addition to LH in Mouse Leydig Tumor Cell.
在体外添加 LH 情况下,用于 FSH、TSH、PTH、Kp 和 OT 的高敏生物测定法在小鼠 Leydig 肿瘤细胞中的应用。
Int J Mol Sci. 2023 Jul 27;24(15):12047. doi: 10.3390/ijms241512047.
4
Inverse correlation of intact PTH, oxidized PTH as well as non-oxidized PTH with 25-hydroxyvitamin D3 in kidney transplant recipients.在肾移植受者中,完整的甲状旁腺激素、氧化的甲状旁腺激素和非氧化的甲状旁腺激素与 25-羟维生素 D3 呈负相关。
Front Endocrinol (Lausanne). 2023 May 31;14:1178166. doi: 10.3389/fendo.2023.1178166. eCollection 2023.
5
Association between multiple vitamins and bone mineral density: a cross-sectional and population-based study in the NHANES from 2005 to 2006.多种维生素与骨密度的关系:2005 年至 2006 年 NHANES 的横断面和基于人群的研究。
BMC Musculoskelet Disord. 2023 Feb 10;24(1):113. doi: 10.1186/s12891-023-06202-6.
6
Interpretation of Parathyroid Hormone Levels in Renal Impairment.肾功能损害时甲状旁腺激素水平的解读
Cureus. 2022 Jun 10;14(6):e25819. doi: 10.7759/cureus.25819. eCollection 2022 Jun.
7
Bone Fragility in Chronic Kidney Disease Stage 3 to 5: The Use of Vitamin D Supplementation.慢性肾脏病3至5期的骨脆性:维生素D补充剂的应用
Metabolites. 2022 Mar 20;12(3):266. doi: 10.3390/metabo12030266.
8
Longitudinal Bone Loss Occurs at the Radius in CKD.慢性肾脏病患者桡骨出现纵向骨丢失。
Kidney Int Rep. 2021 Mar 31;6(6):1525-1536. doi: 10.1016/j.ekir.2021.03.874. eCollection 2021 Jun.
9
Vitamin K and D Supplementation and Bone Health in Chronic Kidney Disease-Apart or Together?维生素 K 和 D 补充与慢性肾脏病的骨骼健康——分开还是一起?
Nutrients. 2021 Mar 1;13(3):809. doi: 10.3390/nu13030809.
10
Traditional and Non-traditional Risk Factors for Osteoporosis in CKD.慢性肾脏病患者骨质疏松的传统和非传统危险因素。
Calcif Tissue Int. 2021 Apr;108(4):496-511. doi: 10.1007/s00223-020-00786-0. Epub 2021 Feb 14.